| P/E (FY) | — | Sales (TTM) | $17.1M |
| Earnings (TTM) | -$16.7M | ROE | — |
| Net Margin | −91.50% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −9.41% |
| Market Cap | $53.1M | Trading Days | 945 |
| 52W High | 2.50 |
| 52W Low | 0.21 |
| % Off High | −16.00% |
| YTD | 232.81% | 1Y | 60.31% |
| 3Y | 19.32% | Since incept. (ann.) | −15.69% |
Third Party Administrator Services 100%
| Ann. Volatility (1Y) | 176.20% | Ann. Volatility (3Y) | 176.13% |
| Sharpe (1Y) | 1.09 | Sharpe (3Y) | 0.85 |
| Max Drawdown (1Y) | −86.23% | Max Drawdown (3Y) | −92.06% |
| Beta (3Y, vs SPY) | 9.43 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| PARK | Park Dental Partners, Inc. | $79.7M | — |
| CCEL | CRYO CELL INTERNATIONAL INC | $27.2M | — |
| MGRX | MANGOCEUTICALS, INC. | $9.5M | — |
| VMD | VIEMED HEALTHCARE, INC. | $446.6M | 31.5 |
| BRTX | BioRestorative Therapies, Inc. | $6.3M | — |
| PGNY | Progyny, Inc. | $2.46B | 48.3 |
| SHC | Sotera Health Co | $5.00B | 64.9 |
| DVA | DAVITA INC. | $15.47B | 24.5 |
| AGL | agilon health, inc. | $41.04B | — |
| FMS | Fresenius Medical Care AG | — | — |
| LUNG | Pulmonx Corp | $52.8M | — |
| TRMED.OL |
| THOR MEDICAL ASA |
| $52.7M |
| — |
